Recent News

Recent News

Jun

08
2011

Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products

East Brunswick and Edison, NJ, USA – Amerigen Pharmaceuticals Limited and AustarPharma, LLC today announced they had entered into a broad-based collaboration agreement regarding the development of generic oral controlled release products. Under the terms of the agreement, AustarPharma will use its proprietary technologies to develop and manufacture products for Amerigen to commercialize in the United States and other territories. AustarPharma received an up-front fee and is eligible for additional product-specific development milestones, plus manufacturing revenues and royalties on any commercialized products. “This collaboration allows Amerigen to augment its internal product development activities and accelerate the company’s efforts to build

Read more »


May

23
2011

Amerigen Adds Several Key Positions in Suzhou, China

Suzhou, China, May 23 2011 – Amerigen Pharmaceuticals announced today the appointment of several key positions who will be based at company’s facility in Suzhou, China. Hui Hua joins Amerigen as Director of Manufacturing. Ms. Hua will be responsible for managing all the manufacturing operations at Amerigen’s Suzhou plant. Ms. Hua has more than 20 years of experience in pharmaceutical and medical device manufacturing. Prior to joining Amerigen, Ms. Hua was manufacturing manager at BD Rapid Diagnostics (Suzhou) where she was responsible for making Class II medical devices for the US market. Prior to BD, Ms. Hua worked at Eli

Read more »


May

20
2011

Amerigen Announces Hiring of New Director of Clinical Operations

East Brunswick NJ, USA, May 20 2011 – Amerigen Pharmaceuticals announced today the appointment of Lorenzo Castro, M.D., MHA as Director of Clinical Operations. Dr. Castro will be responsible for managing the clinical and bioequivalence studies needed to support Amerigen’s product development activities. He will be based at the Company’s offices in East Brunswick, NJ. Dr. Castro joins Amerigen from KV Pharmaceuticals where he was most recently responsible for pharmacovigilance activities. Prior to that, Dr Castro had roles in clinical and regulatory affairs, working on Phase I, II and III studies as well as IND’s, NDA’s and ANDA’s. Prior to

Read more »


1

2

3